Drugs / NW Roselle
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06141200 | Mar 2024 → Apr 2025 | essential hypertension | Natural Wellness Egypt | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NW Roselle | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06141200 ↗ |
| Route | Oral | “Patients will take two capsules of NW Roselle and one placebo tablet orally BID on an empty stomach” NCT06141200 ↗ |